oestradiol

AssetSmall moleculeAlso BAY86-4891, Estradiol / Drospirenone, BAY98-7078, Estradiol Valerate (EV) / Levomefolate Calcium

Estrogen receptor agonist for hormone replacement

Stage: Approved
Modality: Small molecule
Target: ESR2
Indications: 32
Trials: 176
Developers: 9

Indications

32

Atrophic vaginitis
Approvedaccessdata.fda.gov7 Oct 2026
Hypogonadism
Approvedaccessdata.fda.gov7 Oct 2026
Menopause
Approvedaccessdata.fda.gov7 Oct 2026

29 more

Targets and what it contains3
Owner and partners9
Trials176
Evidence for its targets4
Competitors12
Aging relevance1
Signals7

Every asset’s record: target, stage, trials and the evidence behind it.

Updated 7 Oct 2026 · 54 sources